Arbutus Biopharma Corp (ABUS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
William H. Collier
Employees:
90
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
604-419-3200
-
Formally known as:
- Tekmira Pharma
Date | Ratio |
---|---|
2010-11-04 | 1:5 |
Arbutus Biopharma Corporation develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate. AB-836, an oral capsid inhibitor that suppresses HBV DNA replication, is in Phase Ia/Ib clinical trial targeted to hepatocytes.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|